Outcomes from treating tuberculosis with rifampicin or rifabutin in HIV-infected persons also receiving antiretroviral therapy.

Timothy M Rawson BSc MBBS, Nataliya Brima MSc, Fahad AlMajid MD FRCP, Anton L Pozniak MD FRCP, Azara Janmohamed PhD MRCP, Sundhiya Mandalia PhD, Sheena Basnayake RGN, Lusha Kellgren RGN, Andrew J Copas PhD, Robert F Miller MBBS FRCP Imperial College London, London, UK Research Department of Infection and Population Health, University College London, London, WC1E 6JB, UK St Stephen’s Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK TB Service, Ground Floor, Rosenheim Building, University College London Hospitals NHS Foundation Trust, London, WC1E 6AU, UK